Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)

por Cedrés, Susana, Ponce-Aix, Santiago, Zugazagoitia, Jon, Sansano, Irene, Enguita, Ana, Navarro-Mendivil, Alejandro, Martinez-Marti, Alex, Martinez, Pablo, Felip, Enriqueta
Publicado 2015

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

por Haakensen, Vilde Drageset, Nowak, Anna K., Ellingsen, Espen Basmo, Farooqi, Saima Jamil, Bjaanæs, Maria Moksnes, Horndalsveen, Henrik, Mcculloch, Tine, Grundberg, Oscar, Cedres, Susana M., Helland, Åslaug
Publicado 2021

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

por Callejo, Ana, Frigola, Joan, Iranzo, Patricia, Carbonell, Caterina, Diaz, Nely, Marmolejo, David, Assaf, Juan David, Cedrés, Susana, Martinez-Marti, Alex, Navarro, Alejandro, Pardo, Nuria, Amat, Ramon, Felip, Enriqueta
Publicado 2021

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC

por Frigola, Joan, Carbonell, Caterina, Iranzo, Patricia, Pardo, Nuria, Callejo, Ana, Cedres, Susana, Martinez-Marti, Alex, Navarro, Alejandro, Soleda, Mireia, Jimenez, Jose, Hernandez-Losa, Javier, Vivancos, Ana, Felip, Enriqueta, Amat, Ramon
Publicado 2022

Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients

por Martinez, Pablo, Hernández-Losa, Javier, Cedrés, Susana, Castellví, Josep, Martinez-Marti, Alex, Tallada, Natalia, Murtra-Garrell, Nuria, Navarro-Mendivill, Alejandro, Rodriguez-Freixinos, Victor, Canela, Mercedes, Ramon y Cajal, Santiago, Felip, Enriqueta
Publicado 2013

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

por Yamamoto, Nobuyuki, Hayashi, Hidetoshi, Planchard, David, Morán, Teresa, Gregorc, Vanesa, Dowell, Jonathan, Sakai, Hiroshi, Yoh, Kiyotaka, Nishio, Makoto, Cortot, Alexis B., Benhadji, Karim A., Soni, Nital, Huang, Jinhong, Makris, Lukas, Cedres, Susana
Publicado 2020

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort

por Cedres, Susana, Assaf, Juan-David, Iranzo, Patricia, Callejo, Ana, Pardo, Nuria, Navarro, Alejandro, Martinez-Marti, Alex, Marmolejo, David, Rezqallah, Alejandra, Carbonell, Caterina, Frigola, Joan, Amat, Ramon, Pedrola, Anna, Dienstmann, Rodrigo, Felip, Enriqueta
Publicado 2021

Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer

por Iranzo, Patricia, Callejo, Ana, Assaf, Juan David, Molina, Gaspar, Lopez, Daniel Esteban, Garcia-Illescas, David, Pardo, Nuria, Navarro, Alejandro, Martinez-Marti, Alex, Cedres, Susana, Carbonell, Caterina, Frigola, Joan, Amat, Ramon, Felip, Enriqueta
Publicado 2022

ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment

por Ponce, Santiago, Cedrés, Susana, Ricordel, Charles, Isambert, Nicolas, Viteri, Santiago, Herrera-Juarez, Mercedes, Martinez-Marti, Alex, Navarro, Alejandro, Lederlin, Mathieu, Serres, Xavier, Zugazagoitia, Jon, Vetrhus, Sylvia, Jaderberg, Magnus, Hansen, Thomas Birkballe, Levitsky, Victor, Paz-Ares, Luis
Publicado 2023

Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

por Carbonell, Caterina, Frigola, Joan, Pardo, Nuria, Callejo, Ana, Iranzo, Patricia, Valdivia, Augusto, Priano, Ilaria, Cedrés, Susana, Martinez‐Marti, Alex, Navarro, Alejandro, Lenza, Laura, Soleda, Mireia, Gonzalo‐Ruiz, Javier, Vivancos, Ana, Sansó, Miriam, Carcereny, Enric, Morán, Teresa, Amat, Ramon, Felip, Enriqueta
Publicado 2023

Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation

por Cedrés, Susana, Felip, Enriqueta, Cruz, Cristina, Martinez de Castro, Ana, Pardo, Nuria, Navarro, Alejandro, Martinez-Marti, Alex, Remon, Jordin, Zeron-Medina, Jorge, Balmaña, Judith, Llop-Guevara, Alba, Miquel, Josep M, Sansano, Irene, Nuciforo, Paolo, Mancuso, Francesco, Serra, Violeta, Vivancos, Ana
Publicado 2018

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer

por Frigola, Joan, Navarro, Alejandro, Carbonell, Caterina, Callejo, Ana, Iranzo, Patricia, Cedrés, Susana, Martinez‐Marti, Alex, Pardo, Nuria, Saoudi‐Gonzalez, Nadia, Martinez, Debora, Jimenez, Jose, Sansano, Irene, Mancuso, Francesco M., Nuciforo, Paolo, Montuenga, Luis M., Sánchez‐Cespedes, Montse, Prat, Aleix, Vivancos, Ana, Felip, Enriqueta, Amat, Ramon
Publicado 2021

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients

por Cedres, Susana, Serna, Garazi, Gonzalez-Medina, Alberto, Valdivia, Augusto, Assaf-Pastrana, Juan David, Iranzo, Patricia, Callejo, Ana, Pardo, Nuria, Navarro, Alejandro, Martinez-Marti, Alex, Priano, Ilaria, Fasani, Roberta, Guardia, Xavier, Gonzalo, Javier, Carbonell, Caterina, Frigola, Joan, Amat, Ramon, Navarro, Victor, Dienstmann, Rodrigo, Vivancos, Ana, Nuciforo, Paolo, Felip, Enriqueta
Publicado 2023